HRT Financial’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-37,255
Closed -$2.02M – 4274
2026
Q1
$2.02M Buy
+37,255
New +$2.45M 0.01% 1613
2025
Q1
– Sell
-3,869
Closed -$395K – 2578
2024
Q4
$395K Sell
3,869
-8,344
-68% -$956K ﹤0.01% 1564
2024
Q3
$1.29M Buy
12,213
+7,597
+165% +$776K 0.01% 1095
2024
Q2
$429K Sell
4,616
-10,807
-70% -$1.15M ﹤0.01% 1358
2024
Q1
$2.01M Buy
15,423
+7,138
+86% +$839K 0.01% 567
2023
Q4
$938K Buy
8,285
+4,604
+125% +$399K 0.01% 1023
2023
Q3
$302K Sell
3,681
-10,514
-74% -$924K ﹤0.01% 1650
2023
Q2
$1.33M Buy
+14,195
New +$1.13M 0.01% 781
2022
Q4
– Sell
-13,816
Closed -$857K – 2510
2022
Q3
$857K Buy
+13,816
New +$995K 0.01% 1036
2022
Q1
– Sell
-3,322
Closed -$318K – 3143
2021
Q4
$318K Buy
+3,322
New +$225K ﹤0.01% 2225
2021
Q2
– Sell
-28,684
Closed -$1.12M – 2884
2021
Q1
$1.12M Buy
28,684
+7,694
+37% +$299K 0.01% 1009
2020
Q4
$614K Buy
+20,990
New +$537K 0.01% 919

Other funds holding BXC

HRT Financial's BXC Position: Q2 2026 in Review

HRT Financial sold out of BlueLinx (BXC) in Q2 2026, closing a stake of 37,255 shares — an estimated $2.02M sold.

HRT Financial first reported a position in BXC in Q4 2020 and held it in 12 quarters. The position peaked at $2.02M in Q1 2026. 157 funds tracked by Wall St. Rank hold BXC as of Q2 2026.

  • HRT Financial reported no remaining BlueLinx position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 37,255 BlueLinx shares in Q2 2026, an estimated $2.02M.
  • HRT Financial first reported a position in BlueLinx in Q4 2020 and held it in 12 quarters.
  • HRT Financial's BlueLinx position peaked at $2.02M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held BlueLinx as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.